NCT01586455 - Human Placental-Derived Stem Cell Transplantation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2020

Study Completion Date

September 30, 2022

Conditions

Mucopolysaccharidosis IMucopolysaccharidosis VIAdrenoleukodystrophyNiemann-Pick DiseaseMetachromatic LeukodystrophyWolman DiseaseKrabbe's DiseaseGaucher's DiseaseFucosidosisBatten DiseaseSevere Aplastic AnemiaDiamond-Blackfan AnemiaAmegakaryocytic ThrombocytopeniaMyelodysplastic SyndromeAcute Myelogenous LeukemiaAcute Lymphocytic Leukemia

Interventions

DRUG

Human Placental Derived Stem Cell

Infusions of thawed HPDSC to be given following UCB infusion.

Trial Locations (3)

10595

New York Medical College, Valhalla

Unknown

Children's Hospital Colorado, Denver

University of Utah, Salt Lake City